Gene	forward	reverse
NPM1	GGACTCACCGGCGTGTTG	GCCTCTTAACATTTCCCACTTCA
mir-17-92 cluster	GTGGCGGGCACTTTGC	TTCCCTTTGCTGCAGTTTAGG
NME1	GAATGACTGCCTACTCCCAAGAG	CACGCACGGAACGCTTCT
BYSL	GCATCCTGGCCTTTCTTCAGT	GAATTTGGGCATTTTTCTCGAA
PAX5	GAGGCCTGTGCGCATACAG	GCACAGTGGGTGGATGCAT
MS4A1 (CD20)	TGCTAACGGCCCATCTTT	ATGGTAGGTCCCTGAGGACAAG
POU2AF1 (BOB1)	GCTGTGTGTGGGTGTGAAGGT	AGAGGAGCTTTTGGGCTCATC
CD79b	CTGTCCCCGACCCCAAA	CGGTGCAGTTACACGTTTTCC
CD79a	TTCCAAAGGCTCAGCAGTGA	GGCCACAATTCCCCTGAGA
NOP56 (intron; negative control)	TTTCCAGGTCAGCGACATTG	CAATGCATGCCAACCCATAG
CCR7 (negative control)	AAAGCCATTTGGGACTATATTCCA	GTGAGAGAAGTGTCCCCATCCT
SEMA4C (negative control)	TTTGCCCAAAGCGTGAGAA	CAGGAAGACCCTTCAATCAACAG
ACTB (endogenous control)	GCCACGGCTGCTTCCA	GAACCGCTCATTGCCAATG
PRAME (endogenous control)	TCTCCATATCTGCCTTGCAGAGT	GCACGTGGGTCAGATTGCT
